MTSR(Delisted)
MetseraยทNASDAQ
--
--(--)
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About MTSR
Metsera, Inc.
A clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulating hormones
3 World Trade Center, 175 Greenwich Street, New York, New York 10007
--
Metsera, Inc., was originally incorporated under the laws of the State of Delaware on June 29, 2022. The company is a clinical-stage biotechnology company developing next-generation injectable and oral trophic stimulating hormones, or NUSH, analog peptides, for the treatment of obesity, overweight and related diseases.
Company Financials
EPS
MTSR has released its 2025 Q3 earnings. EPS was reported at -1.11, versus the expected -0.68, missing expectations. The chart below visualizes how MTSR has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
No Data
You can ask Aime
No Data
